Absci (ABSI) FCF Margin (2020 - 2026)
Absci (ABSI) posted FCF Margin of 12249.77% for Q1 2026, down 173.82% sequentially from 4473.69% in Q4 2025, and down 1039531.0% YoY from N/an in Q1 2025.
Absci (ABSI) FCF Margin (2020 - 2026) Analysis & Trends
Absci has reported FCF Margin for 7 years, with the latest figure at 12249.77% in Q1 2026.
- Quarterly FCF Margin fell 1039531.0% year-over-year to 12249.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5365.2% (down 377004.0% YoY) and the FY2025 annual result came in at 3358.29%, down 175251.0% from the prior year.
- FCF Margin retreated to 12249.77% in Q1 2026 per ABSI's latest filing, from 4473.69% in the prior quarter.
- Over five years, FCF Margin peaked at 569.82% in Q2 2023 and troughed at 12249.77% in Q1 2026.
- A 5-year average of 3651.81% and a median of 2124.45% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2026: FCF Margin soared 756801 bps in 2023, then tumbled 1039531 bps in 2026.
- Over 5 years, FCF Margin stood at 867.26% in 2022, then slumped by 409 bps to 4414.79% in 2023, then jumped by 41 bps to 2600.9% in 2024, then plunged by 72 bps to 4473.69% in 2025, then sank by 174 bps to 12249.77% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 12249.77%, 4473.69%, and 6876.46% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | -8,668.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8,668.24% |
| Mar 31, 2026 | -12,249.77% |
| Dec 31, 2025 | -4,473.69% |
| Sep 30, 2025 | -6,876.46% |
| Jun 30, 2025 | -2,882.97% |
| Mar 31, 2025 | -1,854.45% |
| Dec 31, 2024 | -2,600.90% |
| Sep 30, 2024 | -1,203.47% |
| Jun 30, 2024 | -1,352.44% |
| Mar 31, 2024 | -1,989.20% |
| Dec 31, 2023 | -4,414.79% |
| Sep 30, 2023 | -1,382.12% |
| Jun 30, 2023 | -569.82% |
| Mar 31, 2023 | -1,595.35% |
| Dec 31, 2022 | -867.26% |
| Sep 30, 2022 | -8,950.14% |
| Jun 30, 2022 | -2,124.45% |
| Mar 31, 2022 | -6,693.42% |
| Dec 31, 2021 | 622.29% |
| Sep 30, 2021 | -816.11% |